巨细胞动脉炎中调节性T细胞功能障碍的新机制与治疗靶点
该研究分析了41例巨细胞动脉炎(GCA)患者(活动期14例、缓解期27例)与健康供者调节性T细胞(Treg)的转录组和表型,发现GCA来源Treg存在27个差异调控基因,涉及转录因子、糖酵解酶和IL-2信号介质。抑制健康供者Treg的糖酵解可重现GCA Treg的大部分功能障碍,提示糖酵解和钙信号低下是Treg功能障碍及GCA炎症的核心机制;托珠单抗治疗患者中Treg抑制功能与疾病缓解相关。
要点
- GCA患者Treg存在FOXP3和IRF4蛋白下调及GARP、CD25诱导不足。
- GCA Treg的TCR诱导钙内流减少,糖酵解抑制可重现该功能障碍。
- 托珠单抗治疗缓解者Treg钙内流和抑制功能恢复。
核心结论
- 低糖酵解和钙信号异常导致GCA中Treg功能障碍和炎症。
研究设计与样本
- 研究纳入41例GCA患者(活动期14例、缓解期27例)和健康供者,分选Treg进行转录组和表型分析。
主要发现
- GCA来源与健康供者来源Treg间有27个差异调控基因,包括转录因子、糖酵解酶和IL-2信号介质。
- GCA Treg中FOXP3和IRF4蛋白下调,GARP和CD25诱导无效,TCR诱导钙内流减少。
- 抑制健康供者Treg糖酵解可重现GCA Treg的大部分功能障碍。
- 托珠单抗治疗亚组分析显示TCR诱导钙内流和Treg抑制功能恢复与疾病缓解相关。
临床怎么用
- 靶向Treg糖酵解和钙信号可能成为GCA治疗新策略。
- 托珠单抗治疗中Treg功能恢复与缓解相关,支持其免疫调节作用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Giant cell arteritis (GCA) is the most common primary vasculitis, preferentially affecting the aorta and its large-calibre branches. An imbalance between proinflammatory CD4+ T helper cell subsets and regulatory T cells (Tregs) is thought to be involved in the pathogenesis of GCA and Treg dysfunction has been associated with active disease. Our work aims to explore the aetiology of Treg dysfunction and the way it is affected by remission-inducing immunomodulatory regimens. METHODS: A total of 41 GCA patients were classified into active disease (n=14) and disease in remission (n=27). GCA patients' and healthy blood donors' (HD) Tregs were sorted and subjected to transcriptome and phenotypic analysis. RESULTS: Transcriptome analysis revealed 27 genes, which were differentially regulated between GCA-derived and HD-derived Tregs. Among those, we identified transcription factors, glycolytic enzymes and IL-2 signalling mediators. We confirmed the downregulation of forkhead box P3 (FOXP3) and interferon regulatory factor 4 (IRF4) at protein level and identified the ineffective induction of glycoprotein A repetitions predominant (GARP) and CD25 as well as the reduced T cell receptor (TCR)-induced calcium influx as correlates of Treg dysfunction in GCA. Inhibition of glycolysis in HD-derived Tregs recapitulated most identified dysfunctions of GCA Tregs, suggesting the central pathogenic role of the downregulation of the glycolytic enzymes. Separate analysis of the subgroup of tocilizumab-treated patients identified the recovery of the TCR-induced calcium influx and the Treg suppressive function to associate with disease remission. CONCLUSIONS: Our findings suggest that low glycolysis and calcium signalling account for Treg dysfunction and inflammation in GCA.
引用
- Adriawan IR, Atschekzei F, Dittrich-Breiholz O, et al. Novel aspects of regulatory T cell dysfunction as a therapeutic target in giant cell arteritis. Ann Rheum Dis. 2021. PMID: 34583923. doi:10.1136/annrheumdis-2021-220955
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。